Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 4, 2011, Pages 316-318

  Tan, Che Kim ^a   Kao, Chiang Lian ^b   Shih, Jin Yuan ^c   Lee, Li Na ^c   Hung, Chien Ching ^c   Lai, Chih Cheng ^d   Huang, Yu Tsung ^c   Hsueh, Po Ren ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Department of Clinical Laboratory Sciences and Medical Biotechnology ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d CARDINAL TIEN HOSPITAL   (Taiwan)

Author keywords

Coinfection; Mycobacterium tuberculosis; Pandemic influenza A (H1N1) virus

Indexed keywords

ANTIINFECTIVE AGENT; CEFUROXIME; ETHAMBUTOL; ISONIAZID; OSELTAMIVIR; PYRAZINAMIDE; RIFAMPICIN;

2009 H1N1 INFLUENZA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA VIRUS A H1N1; LUNG AUSCULTATION; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MIXED INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; ORTHOMYXOVIRUS INFECTION; PHYSICAL EXAMINATION; PHYSICIAN; PLEURA EFFUSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; THROAT CULTURE; WHEEZING;

HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 79959562945     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2010.03.001     Document Type: Article

References (8)

1. World Health Organization Global tuberculosis control: surveillance, planning, financing 2009, WHO report. Available at:. http://www.who.int/tb/publications/global_report/2009/key_points/.
2. Center for Disease Control for Taiwan. Statistics of communicable diseases and surveillance report, Republic of China. Available at: 2009. http://www.cdc.gov.tw/public/Data200.pdf.
3. Lai C.C., Tan C.K., Huang Y.T., Chou C.H., Hung C.C., Yang P.C., et al. Extensively-drug resistant Mycobacterium tuberculosis during a trend of declining drug resistance between 2000 and 2006 at a medical center in Taiwan. Clin Infect Dis 2008, 47:e57-63.
4. Morens D.M., Taubenberger J.K., Fauci A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008, 198:962-970.
5. Brundage J.F., Shanks G.D. Deaths from bacterial pneumonia during the 1918-19 influenza pandemic. Emerg Infect Dis 2008, 14:1193-1199.
6. CDC Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States. MMWR Morb Mortal Wkly Rep May-August 2009, 58:1071-1074.
7. Archer B., Cohen C., Naidoo D., Thomas J., Makunga C., Blumberg L., et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill 2009, 14:19369.
8. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009, 302:1896-1902.